Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Pharmacogenomics|December 15, 2010
Learning from product labels and label changes: how to build pharmacogenomics into drug-development programsLinda C Surh, Michael A Pacanowski, Susanne B Haga, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 16, 2010
NCCN Oncology Risk Evaluation and Mitigation Strategies White Paper: Recommendations for StakeholdersPhilip E Johnson, George Dahlman, Kirby Eng, et al.The Pan African Medical Journal|November 7, 2019
[HIV-2 infection in Senegal: virological failures and resistance to antiretroviral drugs (ARVs)]Selly Ba, Ndeye Mery Dia-Badiane, Stephen Edward Hawes, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2011
NCCN Biosimilars White Paper: regulatory, scientific, and patient safety perspectivesAndrew D Zelenetz, Islah Ahmed, Edward Louis Braud, et al.JAMA Dermatology|September 21, 2022
Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis: The VIP-A Phase 4, Open-label, Nonrandomized Clinical TrialJoel M Gelfand, Daniel B Shin, April W Armstrong, et al.The Journal of Investigative Dermatology|February 24, 2020
A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)Joel M Gelfand, Daniel B Shin, Kristina Callis Duffin, et al.Pageof 2